Drug - Tretinoin
The trade name of the product as shown on the labeling.

The product dosage form and route separated by a semi-colon.

Active Ingredient(s) - Tretinoin
Multiple ingredients are in alphabetical order.

Strength - 0.05%
The potency of the active ingredient(s), Tretinoin. May repeat for multiple part products.

Applicant - SPEAR PHARMS
The firm name holding legal responsibility for Tretinoin. The firm name is condensed to a maximum twenty character unique string.

New Drug Application (NDA) Number - 076498
The FDA assigned number to Tretinoin. Format is nnnnnn.

Product Number - 001
The FDA assigned number to identify Tretinoin. Each strength is a separate product. May repeat for multiple part products. Format is nnn.

Therapeutic Equivalence (TE) Code - AB2
The TE Code indicates the therapeutic equivalence rating of generic to innovator Rx products.

Approval Date - Sep 15, 2005
The date Tretinoin was approved as stated in the FDA approval letter to the applicant. The format is Mmm dd, yyyy. Products approved prior to the January 1, 1982 contain the phrase: "Approved prior to Jan 1, 1982".

Reference Listed Drug (RLD) - No
The pioneer or innovator of Tretinoin. The RLD identifies the product Abbreviated New Drug Applications (ANDA) use as a reference. Format is Yes or No.

Type - RX
The group or category of approved drugs Tretinoin is in. Format is RX, OTC, DISCN.

Applicant Full Name - Spear Pharmaceuticals Inc
The full name of the firm holding legal responsibility for the new application of Tretinoin.